Q2 2024 EPS Estimates for Maximus, Inc. Lifted by Analyst (NYSE:MMS)

Maximus, Inc. (NYSE:MMS - Free Report) - Research analysts at Zacks Research increased their Q2 2024 earnings per share (EPS) estimates for shares of Maximus in a research note issued to investors on Tuesday, April 23rd. Zacks Research analyst R. Department now expects that the health services provider will post earnings per share of $1.33 for the quarter, up from their prior forecast of $1.31. The consensus estimate for Maximus' current full-year earnings is $5.41 per share. Zacks Research also issued estimates for Maximus' Q4 2024 earnings at $1.38 EPS, FY2024 earnings at $5.39 EPS, Q3 2025 earnings at $1.35 EPS, Q4 2025 earnings at $1.42 EPS and Q2 2026 earnings at $1.06 EPS.

A number of other equities research analysts have also recently issued reports on MMS. Raymond James cut Maximus from an "outperform" rating to a "market perform" rating in a report on Wednesday, January 3rd. StockNews.com upgraded Maximus from a "hold" rating to a "buy" rating in a research note on Thursday, February 8th.

Maximus Stock Down 0.2 %

Shares of NYSE:MMS traded down $0.16 during midday trading on Wednesday, reaching $80.82. The company had a trading volume of 216,966 shares, compared to its average volume of 335,095. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.71. The business's 50 day moving average price is $82.63 and its 200 day moving average price is $81.30. The stock has a market cap of $4.93 billion, a PE ratio of 26.76 and a beta of 0.72. Maximus has a 1-year low of $72.39 and a 1-year high of $89.69.

Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings data on Wednesday, February 7th. The health services provider reported $1.34 EPS for the quarter, beating analysts' consensus estimates of $1.28 by $0.06. Maximus had a return on equity of 15.68% and a net margin of 3.73%. The firm had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.29 billion. During the same period last year, the company earned $0.94 EPS. The business's quarterly revenue was up 6.2% compared to the same quarter last year.

Hedge Funds Weigh In On Maximus

Several large investors have recently added to or reduced their stakes in MMS. SG Americas Securities LLC bought a new stake in shares of Maximus in the 3rd quarter worth approximately $2,262,000. GHP Investment Advisors Inc. raised its holdings in shares of Maximus by 3.9% in the 3rd quarter. GHP Investment Advisors Inc. now owns 27,193 shares of the health services provider's stock worth $2,090,000 after purchasing an additional 1,025 shares during the period. HGK Asset Management Inc. raised its holdings in shares of Maximus by 11.8% in the 3rd quarter. HGK Asset Management Inc. now owns 7,395 shares of the health services provider's stock worth $552,000 after purchasing an additional 782 shares during the period. Cavalier Investments LLC raised its holdings in shares of Maximus by 3.8% in the 3rd quarter. Cavalier Investments LLC now owns 19,200 shares of the health services provider's stock worth $1,434,000 after purchasing an additional 699 shares during the period. Finally, Reinhart Partners LLC. raised its holdings in shares of Maximus by 1.6% in the 3rd quarter. Reinhart Partners LLC. now owns 209,244 shares of the health services provider's stock worth $15,626,000 after purchasing an additional 3,238 shares during the period. Institutional investors own 97.21% of the company's stock.

Insider Activity

In other news, CFO David Mutryn sold 8,000 shares of the firm's stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $83.95, for a total value of $671,600.00. Following the completion of the sale, the chief financial officer now directly owns 5,124 shares in the company, valued at approximately $430,159.80. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 1.40% of the stock is currently owned by company insiders.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 31st. Stockholders of record on Wednesday, May 15th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Tuesday, May 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.48%. Maximus's dividend payout ratio is presently 39.74%.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.